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Abstract
Background: Vitamin D and vitamin D dependent antimicrobial peptides such as Cathelicidin (LL-37) and
β-defensin 2 have an important role in innate and adaptative immunity, but their role in pleural effusions has not
been studied before.
Methods: Serum and pleural fluid samples from 152 patients with pleural effusion were collected, corresponding to
45 transudates and 107 exudates, 51 infectious effusions (14 complicated and 37 non-complicated), 44 congestive
heart failure effusions and 38 malignant effusions. The levels of 25 OH-vitamin D, 1,25-(OH)2-vitamin D, Vitamin D
Binding Protein (VDBP), LL-37 and β-defensin 2, both in serum and pleural fluid were evaluated in this prospective
study. Differences between groups were analysed using unpaired t tests or Mann–Whitney tests. Correlations
between data sets were examined using Pearson correlation coefficient or Spearman rank correlation coefficient.
Diagnostic accuracy was estimated using ROC curve analysis.
Results: Low serum 25 OH vitamin D levels were found in all groups. Infectious effusions (IE) had higher serum and
pleural fluid LL-37 levels compared to congestive heart failure or malignant effusions. Among IE, complicated had
higher serum and pleural fluid LL-37 levels, and lower serum β-defensin-2 levels. Positive correlations were found
between serum 25 OH-vitamin D levels and serum or pleural 1,25-(OH)2-vitamin D levels, and between 1,25-(OH)
2-vitamin D and LL-37 serum. Diagnostic accuracy of the different molecules was moderate at best.
Conclusions: Hypovitaminosis D is highly prevalent in pleural effusions. LL-37 is produced intrapleurally in IE.
This production is higher in complicated IE. No evidence of pleural production of β-defensin 2 was found in
any of the groups. Diagnostic accuracy of the different molecules is at the best moderate for discriminating
different types of effusions.
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Background
Vitamin D modulates maturation, proliferation and
function of different cells of both innate and adaptative
immune system [1]. Vitamin D nutritional status is eval-
uated measuring serum 25 OH vitamin D, the stable
metabolite of vitamin D. This molecule is the precursor
of calcitriol or 1,25 (OH)2 vitamin D, the active meta-
bolite of vitamin D [2]. Hypovitaminosis D is a highly
prevalent situation in hospitalized patients [3]. Multiple
studies have shown that vitamin D and its antimicrobial
dependent molecules play a defensive role in different
infectious diseases such as tuberculosis, bacterial or viral
infections [4–6]. Liu et al. [7] demonstrated that some
M. tuberculosis antigens were recognized by Toll-Like 2/
1 receptors of monocytes and innate immunity cells
(skin, respiratory, digestive and urinary epithelium, etc.).
This was followed by an intracrine activation of 1α-
hydroxylase, synthesis of 1,25 (OH)2 vitamin D, and ac-
tivation of the vitamin D receptor, inducing the synthesis
and release of LL-37 (also known as human cathelicidin)
and β-defensin-2. These molecules have important anti-
microbial effects against virus, bacteria, and fungus in
the lung [5, 6]. On the other hand, Vitamin D-binding
protein (VDBP) is a multifunctional serum protein that
binds vitamin D and its metabolites and transports them
to target tissues [8]. VDBP is also a precursor of a
macrophage activating factor [8].
There are no data in the literature regarding the
prevalence of hypovitaminosis D in pleural effusions.
An old study by Barnes et al. [9] showed that pleural
levels of calcitriol were significantly higher in tubercu-
lous pleural effusions as compared with cardiac effu-
sions, although the number of patients studied was
very small. On the other hand, in tuberculous patients
pleural levels of 1,25 (OH)2 vitamin D were signifi-
cantly higher than serum levels. These data suggested
intrapleural synthesis of 1,25 (OH)2 vitamin D in tuber-
culosis, followed by release to blood. Otherwise, these
aspects have never been studied in non-tuberculous
pleural effusions.
One study measured VDBP in pleural fluid and
serum [10]. Pleural fluid VDBP and VDBP pleural
fluid/serum ratio were significantly higher in bacterial
effusions compared to tuberculous or malignant. How-
ever, no differences were found in the serum VDBP/
total protein ratio.
The possible defensive role of LL-37 in infectious
pleural effusions has never been studied before. On the
other hand, it is known that β-defensin-2 can be produced
in vitro by pleural mesothelial cells when stimulated by
Staphylococcus peptidoglycan [11]. This interesting find-
ing suggests that these cells may have an important role in
innate immunity of the pleural cavity, but there are no
data in vivo in humans.
In this study we aimed to measure serum and pleural
fluid levels of 25 OH vitamin D, 1,25 (OH)2 vitamin D,
VDBP, LL-37 and β-defensin-2 in patients with different
etiological types of pleural effusions. We hypothesized
that infectious effusions should have higher levels of
serum or pleural calcitriol, LL-37 and β-defensin-2,
reflecting a higher inflammatory response.
Methods
Study subjects
This is a prospective study approved by the Ethics
Committee of Cantabria (CEIC Cantabria 25/2012).
All patients gave informed consent to obtain samples
of blood and pleural fluid at diagnosis time. We col-
lected pleural fluid and serum at time of diagnosis of
patients who were admitted in our hospital with the
clinical diagnosis of pleural effusion along a period of
18 months. Patients with diseases or drugs known to
alter vitamin D metabolism or immunological responses
and patients with pleural effusion of unknown ethiology
were excluded. In this way, one hundred and fifty two
patients managed by the same medical team were re-
cruited as explained in Fig. 1.
Classification
Patients were diagnosed of: 1) Congestive heart failure
effusion (CHFE), n = 44, based on clinical grounds, ac-
cording to the AHA guidelines, 2) Malignant effusion
(ME), n = 38, when malignant cells were found in
pleural effusion or pleural biopsy, 3) Infectious effusion
(IE), n = 51, when clinical findings were compatible with
pneumonia and there was response to antimicrobial treat-
ment and/or positive culture results. There was also a
miscellaneous group of 19 patients with pleural effusion
due to other less frequent causes (pulmonary thrombo-
embolism n = 7, pancreatitis n = 6, postoperative n = 5,
and nefrotic syndrome n = 1, that was not separately
analyzed. Pleural fluids were also classified as exudates
n = 107 or transudates n = 45, according to the cause of
the effusion in consonance with Light criteria [12]. Pa-
tients with infectious effusions who received chest tubes
for the treatment were classified as having complicated
effusions (CIE). The decision to place a chest tube was left
to the discretion of the attending physician, although it is
likely that this decision was at least partially influenced by
the biochemical characteristics of the fluid. Finally, we
studied 37 noncomplicated (NCIE) and 14 CIE.
Biochemical analyses
Serum and pleural effusion samples were collected in
the appropriate way for the different assays. Routine
determinations were done using the standard methods
of our Hospital. Serum and pleural fluid aliquots for this
specific study were stored at −80 °C until assayed.
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25 OH vitamin D levels were measured by the auto-
mated chemiluminiscence competitive assay IDS iSYS
(Immunodiagnostic Systems Ltd, Boldon, UK), as previ-
ously reported [13]. Our laboratory is DEQAS (Vitamin
D External Quality Assessment Scheme) certified. We
considered hipovitaminosis D when serum levels of 25
OH vitamin D were lower than 20 ng/ml, according to
the 2011 Food and Nutrition Board dietary references
intakes for vitamin D and calcium. 1,25(OH)2 vitamin
D levels were measured by radioimmunoassay (Dia-
Sorin Inc, Stillwater MN USA). VDBP, LL-37 and β-
defensin-2 levels were measured by ELISA using the
following kits: Quantikine Human Vitamin D Binding
Protein (R&D Systems Europe, Abingdon, UK), HK321
Human LL-37 (Hycult Biotech, Uden, Holland) and
human β-defensin-2 (Alpha Diagnostic International,
San Antonio, TX USA).
Statistical analysis
Data are presented as mean ± SD values for normally
distributed data or median (interquartile range, IQR) for
nonparametric data. Differences between proportions
were calculated using chi-square test. Differences between
groups were analyzed using unpaired t tests or Mann–
Whitney tests. Correlations between data sets were exam-
ined using Pearson (r) correlation coefficient or Spearman
rank (rs) correlation coefficient. Differences were consid-
ered significant for all statistical tests at p values of less
than 0.05. All reported p values are two-sided. Analysis
was performed using statistical computer Software
(IBM SPSS Statistics) version 20.00 for Windows. ROC
curves analysis was performed using software MED-
CALC version 11.6.1.0 (MedCalc Software, Mariakerke,
Belgium). The database and leyend of the database
supporting the conclusions of this article are included
within its additional files.
Results
Tables 1 and 2 show the principal results.
Blood and pleural fluid cytologic and biochemical
parameters
As expected, IE had higher levels of neutrophils and
Lactate dehydrogenase (LDH), and lower pH and glucose
levels in the pleural fluid compared to CHFE. Exudates
had higher levels of pleural fluid leukocytes, neutrophils
and LDH and lower glucose and pH levels than transu-
dates. CIE had a higher level of LDH and a lower pH than
the NCIE.
Serum and pleural fluid vitamin D and vitamin D related
molecules
There were no seasonal differences in the dates of
obtaining the samples of the different groups (p = 0.102).
34 patients (77 %) in the CHFE group, 33 (64 %) in
the IE group and 20 (52 %) in the malignant group had
vitamin D deficiency (p < 0.001). There were 35 (77 %)
patients with transudative effusion presenting serum 25
OH levels below 20 ng/ml and 75 (65 %) in the exuda-
tive group (p =NS). There were 10 patients with 25 OH
levels below 20 ng/ml in the CIE group (71 %) and
23 (62 %) in the NCIE group (p = NS).
ME had higher levels of serum 25OH vitamin D com-
pared to CHFE and IE (p < 0.001 and p = 0.01). Similar
differences were found in 1,25 (OH)2 vitamin D levels
(p = 0.041 and p = 0.019). Exudative effusions had higher
levels of 25 OH vitamin D compared to transudative
effusions (p = 0,019). Pleural fluid levels of 1,25 (OH)2
vitamin D were lower in CHFE compared with infectious
or malignant effusions (p = 0.033 and p < 0.001). No
significant difference was found in serum or pleural fluid
levels of 25 OH vitamin D, 1,25 (OH)2 vitamin D or
VDBP between CIE and NCIE.
Fig. 1 Flow Chart: Vit D = vitamin D; CHFE = Congestive Heart Failure Effusion; NCIE = Non-complicated effusion; CIE = complicated effusion
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Table 1 Biochemical Parameters in Pleural effusion
Parameter IE ME CHFE P Value Exudate Transudate P Value CIE NCIE P Value
WBC (cells/μL) Serum 10715 ± 5088 9435 ± 3451 9453 ± 5403 0.32 10156 ± 4575 9278 ± 5456 0.368 10969 ± 4457 10609 ± 5396 0.834
Pleural 555 (160, 960) 400 (240, 680) 240 (160, 640) o.149 410 (240, 800) 240 (160, 640) 0.046 560 (160, 800) 550 (160, 960) 0.761
N, (%) Serum 74 (68, 80) 71 (61, 76.7) 75 (66, 81) 0.102 74 (68, 80) 74 (62, 81) 0.55 71.5 (68, 80) 74 (65, 81) 0.718
Pleural 50 (17.5, 72.5) 15 (10, 20) 15 (5, 25) 0.001 20 (10, 55) 15 (5, 25) 0.026 58 ± 24 40 ± 29 0.111
pH Pleural 7.23 ± 0.31 7.37 ± 0.07 7.4 ± 0.11 0.03 7.28 ± 0.26 7.4 ± 0.11 0.016 7.03 ± 0.32 7.30 ± 0.29 0.028
Glucose (mg/dL) Pleural 99,47 ± 51.95 109 ± 42 133.67 ± 45.4 0.01 105.05 ± 50.98 133.67 ± 45.43 0.07 78.00 ± 58 107.68 ± 47.61 0.080
LDH (IU/L) Pleural 270 (140, 735) 329 (144, 436) 123 (88, 270) 0.001 283 (134, 528) 119 (84, 261) 0.001 682 (164, 1771) 243 (121, 414) 0.035
IE Infectious effusions, CHFE Congestive heart failure effusions, ME Malignant effusions, CIE Complicated infectious effusions, NCIE Non complicated infectious effusions, WBC White blood cells, N Neutrophils, LDH
















Table 2 Vitamin D related molecules in Pleural effusion
Parameter IE ME CHFE P Value Exudate Transud. P Value CIE NCIE P Value
25OH Vitamin D (ng/mL) Serum 12 (5, 84) 18.4 (6.9, 41) 10,4 (3, 39.6) 0,001 12.8 (5, 84) 10.6 (3, 39,6) 0,019 11.85 (9.2, 16.2) 13.5 (7.6, 22.4) 0.731
Pleura 16 (1, 63) 17 (5.5, 47) 12.2 (1, 30.5 0,016 15 (1, 63) 12 (1, 25) 0,048 16 (9.65, 20.65) 15 (7.75, 25.32) 0.551
1,25 (OH)2 Vitamin D (pg/mL) Serum 25.65 (7, 113) 46 (9, 140) 22.5 (5, 116) 0,043 25.65 (5, 140) 22 (8, 66) 0,708 22 (14.5, 35.5) 32 (8.5, 41.5) 0.751
Pleura 22 (4, 132) 31.5 (0.4, 1.28) 12 (2, 52) 0,001 18 (4, 132) 12 (2, 50) 0,030 22 (12, 34) 21.5 (7.2, 32.5) 0.627
VDBP (mg/L) Serum 203 (29, 494) 275.10 (13.13, 730) 197 (27, 1122) 0,1 236 (13, 730 190 (27, 1122) 0,307 139 (29, 285) 166 (42, 338) 0.71
Pleura 134 (4, 834) 191 (5, 464) 95 (10, 446) 0,001 155 (4, 834) 95 (10, 446) 0,48 85 (10, 183) 217 (30, 258) 0.112
LL-37 (ng/mL) Serum 0.84 (0.01, 153) 0.47 (0.01, 12.62) 0.25 (0.01, 10.34) 0.017 0.67 (0.01, 153) 0,.24 (0.01, 10.3) 0.017 0,51 (0.28, 1.29) 1.43 (0.95, 1.85) 0.029
Pleura 1.42 (0.05, 153) 0.52 (0.01, 13.51) 0.3 (0.01, 3.3) 0.001 0.91 (0.01, 153) 0.3 (0.01, 3.3) 0..001 1.05 (0.47, 4.28) 3.11 (1,62, 5.62) 0.014
β-defensin-2 (pg/mL) Serum 232 (14, 2100) 224 (10, 3000) 284 (9, 1834 0.966 213 (9, 3000) 258 (9, 1834) 0.651 431 (136, 1015) 112 (71, 233) 0.023
Pleura 265.2 (6, 1293) 276 (25, 3000) 241 (5, 2206) 0.706 240 (6, 3000) 214 (5, 2206) 0.484 383 (72, 804) 152 (16, 352) 0.091
IE Infectious effusions, CHFE Congestive heart failure effusions, ME Malignant effusions, CIE Complicated infectious effusions, NCIE Non complicated infectious effusions, WBC White blood cells, N Neutrophils, LDH
















IE had higher levels of serum cathelicidin compared to
CHFPE or ME (p = 0.005 and p = 0.017). Pleural levels of
LL 37 were also higher in the IE group (p = 0.001 and
p = 0.001). Exudative effusions had higher serum levels of
LL-37 compared to transudative effusions (p = 0.017). CIE
had significantly higher levels of LL-37, both in serum
(p = 0.029) and pleural fluid (p = 0.014) compared with
the NCIE group. No differences in serum or pleural
β-defensin-2 levels were found among the different
etiological groups or between exudate and transudate
groups. In contrast, β-defensin-2 serum levels were
lower in CIE (p = 0.023); otherwise, a non-significant
trend for lower levels was found in CIE pleural fluid
compared with the NCIE group (p = 0.091).
Relationships among vitamin D related molecules
When all patients were considered, significant positive
correlations were found between serum and pleural
levels of 25 OH Vitamin D (rs = 0.596, p < 0.001), 1,25
(OH)2 vitamin D (rs = 0.516, p = 0.001), VDBP (rs = 0.870,
p < 0.001), LL-37 (rs = 0.707, p < 0.001) and β-defensin-2
(rs = 0.870, p < 0.001).
Interestingly, serum levels of 25 OH vitamin D also
showed significant positive correlations with pleural
(rs = 0.54, p < 0.001) 1,25 (OH)2 vitamin D levels. Fur-
thermore, serum 1,25 (OH)2 vitamin D levels were
significantly correlated with serum LL-37 levels (rs = 0.388,
p = 0.05), but not with serum β-defensin-2 levels.
On the other hand, vitamin D metabolites and related
molecules did not correlate with glucose, pH, or LDH,
either in serum or in pleural effusion.
Diagnostic accuracy of vitamin D related molecules
Evaluation of ROC plots in serum and pleural fluid sam-
ples taken from patients with effusions for the discrimin-
ation between infectious origin and other origin were
similar for pleural fluid LL-37 [AUC= 0.732 (95 % CI,
0.657-0.798), p < 0.001] and pleural fluid 1,25 (OH)2
vitamin D [AUC = 0.754 (95 % CI, 0.654-0.838), p < 0.001].
Pleural fluid LL-37 [AUC = 0.657 (95 % CI, 0.575-0.733),
p = 0,0016] was superior to serum LL-37 [AUC = 0.586
(95 % CI, 0.503-0.667), p = 0,1181] for the differentiation
between exudative and transudative effusions.
Pleural fluid LL-37 [AUC = 0.731 (95 % CI, 0.585-0.847),
p = 0.0012] and serum β-defensin2 [AUC= 0.731 (95 %
CI, 0.562-0.861), p = 0.0085] were superior to serum LL-
37 [AUC= 0.708 (95 % CI, 0.557-0.831), p = 0.0015] for
the differentiation between CIE and NCIE.
Discussion
In 1998 Thomas et al. [3] showed in an influential paper
that the prevalence of hypovitaminosis D was high in
non-selected inpatient subjects from the medical wards
of the Massachusetts General Hospital in Boston. A
multivariant study demonstrated different factors related
to hypovitaminosis, such as advanced age, insufficient
ingestion of vitamin D or sun exposure, presence of
specific diseases (nephrotic syndrome, malabsorption,
hepatic cirrhosis, morbid obesity etc.) and use of drugs
that increase vitamin D catabolism. In that study no
patients with pleural effusion were included, and since
then the prevalence of hypovitaminosis D in pleural effu-
sions has not been specifically studied. Our study shows,
as expected, that all kinds of pleural effusion are associ-
ated frequently with hypovitaminosis D defined as 25 OH
vitamin D serum levels lower than 20 ng/ml.
Significant lower levels of serum 1,25 (OH)2 vitamin
D were found in CHFE. This might probably be due to
lower levels of 25 OH vitamin D in this group. This is
supported by the positive correlation between 25 OH
vitamin D and 1,25 (OH)2 vitamin D levels. This correl-
ation is typical of hypovitaminosis D, and it means that
the substrate (25 OH vitamin D) is really a limiting
factor for the production of 1,25 (OH)2 vitamin D. If 25
OH vitamin D levels were normal (plenty of substrate)
this correlation should not be found. No significant
differences were found in either serum or pleural fluid
levels of 25 OH vitamin D, 1,25 (OH)2 vitamin D or
VDBP in CIE vs. NCIE. We had hypothesized that
pleural 1,25 (OH)2 vitamin D could be increased in
complicated patients, but our data does not support this
hypothesis. This can be due, at least in part, to the fact
that low levels of the precursor molecule 25 OH vitamin
D limit the production of 1,25 (OH)2 vitamin D. Fur-
thermore, the paracrine/intracrine production of calci-
triol in response to the infection, may not be enough to
induce measurable changes in pleural fluid or serum.
On the other hand, we found higher levels of LL-37
both in serum and pleural fluid in IE, specially in CIE,
suggesting that, despite hypovitaminosis D, innate im-
mune cells are able to produce higher quantities of this
natural antimicrobial molecule when they are severely
challenged. The positive correlation between serum 1,25
(OH)2 vitamin D and LL-37 suggests that higher levels
of the active metabolite in fact potentiate LL-37 synthe-
sis, even in the presence of hypovitaminosis D. On the
contrary serum β-defensin-2 levels were decreased in
CIE and did not correlate with 1,25 (OH)2 levels. The
different behavior of these antibiotic molecules suggests
that, although both are modulated by vitamin D, other
factors are also importantly involved in their response.
For example, it has been demonstrated in vitro that β-
defensin-2 responses to vitamin D are lower than those
of LL-37 [7]. In vivo, quantity and time course of
response of these molecules to different challenges are
also different [14, 15]. Furthermore it has been reported
that β-defensin-2 decreases in sepsis [16] and lower
plasma level of this substance is an independent predictor
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of adverse outcomes in patients with community-acquired
pneumonia [17]. Further time course studies are needed
to analyze whether this is due to consumption of β-
defensin-2, or because certain patients have lower response
of this molecule leading to susceptibility to sepsis.
Significant positive correlations were found between
serum and pleural levels of all the molecules studied,
suggesting there is good diffusion of these molecules
through the pleural membranes. Otherwise, no correlations
were found with other established pleural biomarkers, such
as pH, glucose or LDH.
Diagnostic accuracy of the different molecules evalu-
ated by ROC analysis is similar or lower to standardized
methods used in clinical practice. These results suggest
that although some vitamin D related molecules could
be markers with relatively good sensitivity and specificity
for pleural effusion evaluation, the cost and time needed
do not support its use as a routine laboratory test.
Our study has limitations. The number of patients
studied is relatively small in some of the groups, espe-
cially in the CIE group, and we have only one determin-
ation, at the time of diagnosis. Subsequent samples
should give a clearer picture of the responses and inter-
actions among all molecules. Likewise, the definition of
CIE and NCIE is never clear-cut. In the present study
CIE were defined as those that received chest tubes. This
decision was made with the knowledge of the pleural
fluid pH, glucose and LDH, and this could have influ-
enced which patients were given chest tubes.
Conclusion
In conclusion hypovitaminosis D is highly prevalent in
all kinds of pleural effusions. LL-37 is higher both in
pleural fluid and blood of the more inflammatory effusions,
but there is a weaker response of β-defensin-2 in blood.
The pathophysiological significance of these findings merits
to be studied in further detail. Also, a clinical trial aimed at
improving the vitamin D nutritional status should test if
vitamin D boosts the innate antibiotic and clinical response
in these patients.
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